What Happened?
, -based LEXEO Therapeutics Appointed Micah Zajic as Chief Financial Officer
About the Company
LEXEO Therapeutics is a New York City-based, fully integrated biotechnology company currently headquartered at the Alexandria Center® for Life Science that aims to apply the transformational science of gene therapy to address some of the world’s most devastating genetic and acquired diseases.
About the Person
Micah Zajic is Chief Financial Officer at LEXEO Therapeutics. Previously, Micah held various senior HR leadership roles in the industry.
Info Source
News
Short Profile